(19)
(11)
EP 0 591 320 A1
(12)
(43)
Date of publication:
13.04.1994
Bulletin 1994/15
(21)
Application number:
92913077.0
(22)
Date of filing:
03.06.1992
(51)
International Patent Classification (IPC):
A61K
35/
14
( . )
A61K
39/
395
( . )
C07K
1/
00
( . )
C07K
14/
00
( . )
C07K
14/
52
( . )
C07K
16/
18
( . )
C12N
5/
10
( . )
C12P
21/
02
( . )
G01N
33/
577
( . )
A61K
38/
00
( . )
A61P
37/
06
( . )
C07K
1/
22
( . )
C07K
14/
435
( . )
C07K
16/
00
( . )
C07K
16/
24
( . )
C12N
15/
02
( . )
G01N
33/
53
( . )
C12R
1/
91
( . )
(86)
International application number:
PCT/US1992/004614
(87)
International publication number:
WO 1992/021240
(
10.12.1992
Gazette 1992/31)
(84)
Designated Contracting States:
AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
(30)
Priority:
03.06.1991
US 19910709375
(71)
Applicant:
LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
La Jolla, CA 92037 (US)
(72)
Inventor:
KIMISHIGE, Ishizaka
La Jolla, CA 92037 (US)
(74)
Representative:
VOSSIUS & PARTNER
Postfach 86 07 67
D-81634 München
D-81634 München (DE)
(54)
SUPPRESSOR T-CELL HYBRIDOMA